SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: tom pope who wrote (9960)10/21/2008 1:45:05 PM
From: Arthur Radley  Read Replies (1) | Respond to of 10345
 
Tom,
The BIIB CC took the starch out of the stock...

"On a conference call with investors, Biogen said it is
holding to its projection that 100,000 patients will be taking
Tysabri by 2010, but acknowledged that growth will have to
accelerate if it is to achieve that goal."



To: tom pope who wrote (9960)10/21/2008 2:51:15 PM
From: SI Bob  Read Replies (1) | Respond to of 10345
 
It's not the first time its price movement has been counter-intuitive when looking at news from BIIB.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News